Pharmaceutical Advertising 2025

Chambers and Partners, 2025 Online Journal

The Law & Practice and Trends & Development chapters in "Pharmaceutical Advertising 2025 | Switzerland" from Chambers and Partners provide an overview of the regulatory environment for pharmaceutical advertising in Switzerland. They highlight the ban on pre-approval promotion and direct-to-consumer (DTC) advertising of prescription medicines. The articles also discuss the narrow limits for permissible pharmaceutical advertising, which depend largely on legal and regulatory expertise as well as extensive practical industry experience. Additionally, they cover the latest developments and compliance issues in the pharmaceutical advertising sector, offering valuable insights for professionals in the field.